Amundi Has $506.57 Million Holdings in Synopsys, Inc. $SNPS

Amundi raised its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 16.8% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 968,384 shares of the semiconductor company’s stock after buying an additional 139,311 shares during the period. Amundi owned about 0.62% of Synopsys worth $506,571,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Brighton Jones LLC lifted its holdings in Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after purchasing an additional 50 shares during the last quarter. Harbour Investments Inc. lifted its stake in shares of Synopsys by 10.8% during the 1st quarter. Harbour Investments Inc. now owns 235 shares of the semiconductor company’s stock worth $101,000 after buying an additional 23 shares during the last quarter. Atria Wealth Solutions Inc. boosted its holdings in shares of Synopsys by 28.9% during the 1st quarter. Atria Wealth Solutions Inc. now owns 5,679 shares of the semiconductor company’s stock worth $2,435,000 after buying an additional 1,272 shares during the period. Vanguard Group Inc. grew its stake in Synopsys by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock valued at $6,359,747,000 after buying an additional 346,994 shares during the last quarter. Finally, Primecap Management Co. CA bought a new position in Synopsys in the 1st quarter valued at about $17,754,000. 85.47% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on SNPS shares. Citigroup started coverage on Synopsys in a report on Monday, November 24th. They set a “buy” rating and a $580.00 price objective for the company. JPMorgan Chase & Co. dropped their price target on Synopsys from $685.00 to $600.00 and set an “overweight” rating for the company in a report on Wednesday, September 10th. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Wall Street Zen downgraded Synopsys from a “hold” rating to a “sell” rating in a report on Saturday, September 13th. Finally, Robert W. Baird reissued a “neutral” rating and issued a $535.00 target price (down previously from $670.00) on shares of Synopsys in a research report on Wednesday, September 10th. Ten investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $555.33.

Insider Transactions at Synopsys

In related news, Director Robert G. Painter purchased 350 shares of the firm’s stock in a transaction that occurred on Thursday, September 11th. The shares were bought at an average cost of $425.44 per share, with a total value of $148,904.00. Following the acquisition, the director owned 2,291 shares of the company’s stock, valued at $974,683.04. This trade represents a 18.03% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the company’s stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the transaction, the chief accounting officer owned 20,520 shares of the company’s stock, valued at approximately $10,278,468. This represents a 32.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.62% of the company’s stock.

Synopsys Stock Performance

Shares of NASDAQ:SNPS opened at $463.74 on Friday. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The stock has a market capitalization of $86.14 billion, a price-to-earnings ratio of 36.40, a price-to-earnings-growth ratio of 5.35 and a beta of 1.16. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. The company’s 50 day simple moving average is $437.46 and its 200 day simple moving average is $505.76.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same period in the prior year, the business posted $3.43 EPS. The company’s revenue for the quarter was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS and its Q4 2025 guidance at 2.760-2.80 EPS. As a group, research analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.